Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: New Jersey 25 trials found
New Search
Filter
Trial Phase
Study Type
Leveraging the Emergency Department (LEAD) Study
NAINTERVENTIONAL Brick, New Jersey +4 more
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
PHASE2INTERVENTIONAL Elizabeth, New Jersey +4 more
RECRUITING
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
PHASE2INTERVENTIONAL Hamilton, New Jersey +4 more
RECRUITING
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
PHASE2INTERVENTIONAL Oxnard, California +4 more
RECRUITING
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
PHASE2INTERVENTIONAL Elizabeth, New Jersey +4 more
RECRUITING
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
PHASE3INTERVENTIONAL La Jolla, California +4 more
RECRUITING
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
PHASE1, PHASE2INTERVENTIONAL Fayetteville, Arkansas +4 more
RECRUITING
Project: Every Child for Younger Patients With Cancer
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
PHASE3INTERVENTIONAL Springdale, Arkansas +4 more
RECRUITING
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
PHASE3INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
An Internet-based Program to Help Cancer Survivors Manage Pain
NAINTERVENTIONAL Fort Smith, Arkansas +4 more
RECRUITING
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
N/AOBSERVATIONAL Fairbanks, Alaska +4 more
RECRUITING
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
NAINTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
N/AOBSERVATIONAL Anchorage, Alaska +4 more
RECRUITING
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
N/AOBSERVATIONAL Anchorage, Alaska +4 more
RECRUITING
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type